Refractory Status Epilepticus Rse clinical trials

Explore recruiting refractory status epilepticus rse clinical trials.

Also recruiting in Europe

Refractory Status Epilepticus Rse trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety, and tolerability of intravenous ganaxolone added to standard of care in refractory status epilepticus

Austria, Denmark, France, Lithuania, Germany, Finland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Refractory Status Epilepticus Rse trials by city

Refractory Status Epilepticus Rse in Toronto Refractory Status Epilepticus Rse in Vancouver Refractory Status Epilepticus Rse in Montreal Refractory Status Epilepticus Rse in Calgary Refractory Status Epilepticus Rse in Edmonton Refractory Status Epilepticus Rse in Ottawa Refractory Status Epilepticus Rse in Winnipeg Refractory Status Epilepticus Rse in Quebec City Refractory Status Epilepticus Rse in Hamilton Refractory Status Epilepticus Rse in Kitchener Refractory Status Epilepticus Rse in London Refractory Status Epilepticus Rse in Halifax Refractory Status Epilepticus Rse in New York Refractory Status Epilepticus Rse in Los Angeles Refractory Status Epilepticus Rse in Chicago Refractory Status Epilepticus Rse in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease